Study of PX-866 and Docetaxel in Solid Tumors

Clinical trial NCT01204099 · COMPLETED

Trial details

NCT number: NCT01204099
Sponsor: Cascadian Therapeutics Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer (NSCLC)Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Start date: 2010-09-01
Primary completion: 2013-12-01
Enrollment: 223

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.